Parenteral nutrition associated liver disease

Stuart S Kaufman1, Gabriel E Gondolesi, Thomas M Fishbein

  • 1Department of Gastroenterology and Nutrition, Children's National Medical Center, 111 Michigan Avenue, N.W. Washington, DC 20010, USA. skaufman@cnmc.org

Insights

Parenteral nutrition (PN) can cause liver disease, especially in infants. New treatments are needed as current options are limited to intestinal adaptation or transplantation.

Area of Science:

  • Gastroenterology and Hepatology
  • Pediatric Nutrition
  • Clinical Research

Background:

  • Parenteral nutrition (PN)-associated liver disease (PNALD) is a common complication, particularly in infants.
  • Cholestasis is the predominant form, ranging from mild bilirubin increases to fatal liver failure.
  • Disease severity correlates with the underlying intestinal issue necessitating PN.

Purpose of the Study:

  • To review the current understanding of PNALD pathogenesis and clinical presentation.
  • To highlight the limitations of existing management strategies for PNALD.
  • To emphasize the need for novel therapeutic interventions.

Main Methods:

  • Review of existing literature on PNALD.
  • Analysis of factors influencing disease severity.
  • Discussion of current and potential treatment modalities.

Main Results:

  • PNALD severity is linked to the extent of intestinal dysfunction and complications like sepsis.
  • Current treatments are limited, with intestinal adaptation or transplantation being the only definitive options.
  • The pathogenesis of PNALD remains incompletely understood.

Conclusions:

  • Effective, less invasive treatments for PNALD are urgently required.
  • Further research, including prospective trials of novel therapies, is crucial for improving patient outcomes.
  • Addressing the underlying intestinal problem is key to managing PNALD.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...